depression

Research explores depression’s ripple effect on diabetes

July 14, 2025 / Depression, Research update / InnovateMed Author / depression, diabetes

by Bridjes O’Neil, Saint Louis University edited by Lisa Lock, reviewed by Andrew Zinin Credit: Nataliya Vaitkevich from Pexels A study conducted by researchers at Saint Louis University found that patients with depression were more likely to have uncontrolled diabetes over time and that depression contributes to a heightened economic burden to diabetes management. The study, published in the Journal […]

Research explores depression’s ripple effect on diabetes Read More »

The ‘Montreal Model’ of ketamine therapy yields more sustained depression relief

June 19, 2025 / Clinical Practice / InnovateMed Author / depression

by McGill University edited by Lisa Lock, reviewed by Andrew Zinin Mean depression ((a) Montgomery–Åsberg Depression Rating Scale (MADRS), (b) Beck Depression Inventory (BDI)), suicidality ((c) Scale for Suicide Ideation (SSI)) and anxiety ((d) State Trait Anxiety Inventory (STAI-A)) scores by group. T-test results represent changes across time, both groups combined. Error bars are standard errors; p-values

The ‘Montreal Model’ of ketamine therapy yields more sustained depression relief Read More »

Psilocybin provides benefit for people with cancer and major depression, clinical trial reveals

June 16, 2025 / Clinical Practice / InnovateMed Author / depression

by Wil Credit: Ivan Samkov from Pexels New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in mushrooms—can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder. The findings are published in Cancer. People with cancer often struggle with depression. In

Psilocybin provides benefit for people with cancer and major depression, clinical trial reveals Read More »

Tailored brain stimulation treatment results offer hope for people with depression

June 11, 2025 / Research update / InnovateMed Author / depression

by QIMR Berghofer edited by Sadie Harley, reviewed by Robert Egan Credit: Pixabay/CC0 Public Domain Medical researchers at QIMR Berghofer have achieved a significant milestone in the treatment of depression, demonstrating the effectiveness of personalized transcranial magnetic stimulation (TMS) therapy. This innovative approach uses advanced brain imaging to tailor treatment to an individual’s unique brain anatomy

Tailored brain stimulation treatment results offer hope for people with depression Read More »

Research explores depression’s ripple effect on diabetes

The ‘Montreal Model’ of ketamine therapy yields more sustained depression relief

Psilocybin provides benefit for people with cancer and major depression, clinical trial reveals

Tailored brain stimulation treatment results offer hope for people with depression

Need Help?

We are here to help.